Daxor Balance Sheet Health

Financial Health criteria checks 2/6

Daxor has a total shareholder equity of $32.7M and total debt of $1.6M, which brings its debt-to-equity ratio to 5.1%. Its total assets and total liabilities are $34.4M and $1.7M respectively.

Key information

5.1%

Debt to equity ratio

US$1.65m

Debt

Interest coverage ration/a
Cashn/a
EquityUS$32.66m
Total liabilitiesUS$1.72m
Total assetsUS$34.38m

Recent financial health updates

Recent updates

Daxor reports Q2 results

Aug 25

Daxor partners with Medaxiom to advance awareness of blood volume diagnostic

Jul 21

Daxor's (NASDAQ:DXR) Earnings Aren't As Good As They Appear

Mar 08
Daxor's (NASDAQ:DXR) Earnings Aren't As Good As They Appear

A Look At The Fair Value Of Daxor Corporation (NYSEMKT:DXR)

Feb 27
A Look At The Fair Value Of Daxor Corporation (NYSEMKT:DXR)

Financial Position Analysis

Short Term Liabilities: DXR's short term assets ($20.1K) do not cover its short term liabilities ($70.6K).

Long Term Liabilities: DXR's short term assets ($20.1K) do not cover its long term liabilities ($1.6M).


Debt to Equity History and Analysis

Debt Level: DXR's net debt to equity ratio (5.1%) is considered satisfactory.

Reducing Debt: DXR's debt to equity ratio has reduced from 32.3% to 5.1% over the past 5 years.

Debt Coverage: DXR's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if DXR's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies